Indigo Company Overview

David was most recently CEO and Co-Founder of Anacor Pharmaceuticals (NASDAQ: ANAC), a biopharmaceutical company discovering and developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. The company was acquired by Pfizer Inc. (NYSE: PFE) in 2016 for approximately $5.2 billion. David previously co-founded and served as CEO of Chemdex (NASDAQ: CMDX), later creating its parent company Ventro Corporation (NASDAQ: VNTR), a business-to-business marketplace focused on the life sciences industry. At its peak, Ventro was valued at $11 billion and was later sold to Nexprise.

David is Founder and Chairman of the San Francisco-based digital health startup, Farewell, and a Director of the human microbiome company, Epiva.

In 2000, David was named Entrepreneur of the Year in Northern California by Ernst and Young. He holds an M.B.A. from Harvard Business School and a B.S. in chemical engineering from the University of Tulsa. He also attended the United States Air Force Academy, where he was a National Merit Scholar. 

Geoffrey served as Chief Technology Officer at Seres Therapeutics, where he led the build-out of the Microbiome Therapeutics platform and the discovery of SER-109, the first clinically-validated Microbiome Therapeutic. He was also VP of Product Discovery at Axcella, where he led the discovery of two clinically-validated drug candidates.

Geoffrey has been named as an inventor on over 100 patents and applications and received more than 20 awards for invention, including the Lemelson-MIT student prize, given to the most innovative student at MIT. He was awarded a Ph.D. in Biomedical Engineering and Medical Physics from MIT; a M.S. in Bioengineering from the University of California, San Diego; and a S.B. in Chemical Engineering from MIT.

de Fontaine spearheaded the company’s overall technology strategy, devised a scalable and customer-oriented technology platform, and led the implementation of business systems to support the launch and growth of the company. Prior to Fresh Formats, de Fontaine spent three years at Ahold USA, the American affiliate of Royal Dutch Ahold and the owner of leading grocery brands such as Stop-and- Shop, Giant, and Peapod. As Vice President of IT Strategy and Architecture there, de Fontaine led the effort to define the technology roadmap for the company, established standards and governance, and launched a technology innovation function.

In addition to high-level leadership experience, de Fontaine brings deep knowledge in IT program delivery, which he acquired through previous roles as Director of IT Business Systems at Anheuser-Busch Inbev and Senior Manager of Business & Systems Integrations at Accenture.